68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

Conditions: Malignant Tumor; Positron Emission Tomography; Fibroblast Activation Protein Inhibitor Interventions: Diagnostic Test: 68Ga-TCR-FAPI PET/CT Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University; Peking University Cancer Hospital& Institute Recruiting

https://clinicaltrials.gov/study/NCT06084767

Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials